Introduction
Gastric cancer is the second most common cancer in cancer-related deaths. It accounts 42% of all gastric cancer cases worldwide [1] , [2] . Helicobacter pylori (H. pylori) colonization is associated with chronic gastritis, gastric ulcer and gastric cancer [3] , [4] , which colonizes 50% of the humans' stomach [5] , [6] . The International research agency for cancer (IRAC) ranked H. pylori as a class I carcinogen [7] . CagA toxin (first bacterial oncoprotein) is one of the most important virulence factor produced by H. pylori [8] , associated with gastric cancer by inducing inflammation, cell proliferation and metastasis [9] , [10] .
Glycosylation is essential in many of the physiological and pathological processes.
H. pylori infection alters the host's glycosylation with the stimulation of specific glycosyltransferases and the sugar antigens such as Lewis blood group antigens [11] , [12] , [3] . Cancers are characterized by altered fucosylation where fucose units are transferred to precursor oligosaccharides by the catalyzation of fucosyltransferases (FUTs) [13] , [14] . High expression of FUT4 promotes cell proliferation through augmenting the synthesis of LeY. LeY is difucosylated oligosaccharide that belongs to A, B, H and Lewis blood group family with the chemical structure [Fucα1→2Galβ1→4(Fucα1→3) GlcNAcβ1→R]. The α 1, 3-fucosylation of LeY is catalyzed by FUT4 [15] . The role of FUT4 fucosylation and α 1,3-fucosylated glycans in the development and progression of H. pylori associated gastric cancer has not been well studied.
MicroRNAs (miRNAs) are small non-coding RNA sequences of about 22
nucleotides that negatively regulate protein expression at the posttranscriptional level [16] , [17] , [18] ; by binding to their 3′ untranslated region (UTR) of target mRNAs [19] , [20] . miRNA involvement in the H. pylori infectious and gastric cancer has been studied [21] , [22] , [23] , [24] but there is need to study the mechanism that how H.
pylori CagA contributes to promote gastric cell proliferation with the activation of miRNA. miRNA-1290 is targeted and altered several potential transcription factors genes [25] , including Foxa1, Smad2, Bach1, MITF, and HoxC13 [26] . FUT4 is regulated by various transcriptional and post-transcriptional factors. SP1 is a well-characterized DNA-binding protein which augments cell growth and metastatic potential of tumor cells [27] . High expression of SP1 is inversely proportional to cancer development and progression [28] , [29] ; and associated with poor prognosis in human cancers such as breast [30] , colon [31] , lung [32] and gastric cancer [33] , [34] .
We previously reported that FUT4 expression is downregulated by SP1 and induce gastric cancer apoptosis [34] , [35] . The role of miRNA-1290 in regulating SP1 transcription factors in gastric cancer has not been studied. We hypothesized that SP1 might be potentially specific target of miRNA-1290 with the overexpression of FUT4/LeY through EGFR/MAPKs pathway for the development of gastric cancer, which might be a new pathogenic mechanism of H. pylori CagA-associated gastric cancer.
Material and Methods

Bacterial cultivation
H. pylori strain (ATCC-43504) was processed and cultured on Colombia agar (CA) plates containing 7% lysed horse blood and antibiotics (Amphotericin B, Trimethoprim, Cefsulodin and Vancomycin). The CA plates were incubated for 3-4 days under microaerophilic conditions at 37 °C, and identification was carried out by different conventional and molecular methods. [36] .
Cytotoxin-associated immunodominant antigen-pathogenicity island protein (Cag
PAI) with type IV system
Transient transfection
Human gastric cancer cells (SGC-7901) were trypsinized and seeded into 6-well plates. When cells reached to 70-80% confluence, FUT4 siRNA was transiently transfected into SGC-7901 cells using 400 ng of plasmid and 2 µl of Lipofectamine™ Reagent and Plus™ Reagent (Invitrogen) according to manufacturer's instructions. The transfection reagent was removed after 12 h and was followed by CagA treatment. Cells were harvested 24 and 48 h post-CagA treatment.
Knockdown and overexpression of miRNA-1290
Cells were plated at 1.5-2×10 3 and 1×10 5 cells per well in 96-and 6-well plates one day before transfection, and at 70% confluency transfected with Dharmacon hsa-miRNA-1290 mimic or hairpin inhibitor with appropriate control of miRNAs at 30nM final concentrations using DharmaFECT-2 transfection reagent according to manufacturer's instructions.
Enzyme-linked immunosorbent assay
Serological assessment of FUT4 and LeY were measured by enzyme-linked immunosorbent assay (ELISA). Commercial ELISA kits were used to analyze serological values of FUT4 according to manufacturer's instructions (Cusabio, US).
LeY serological assessment was detected by in-house ELISA as described [3] , [34] .
Cell proliferation and viability assay
Cells (1 × 10 3 cells/well) were plated in 96-well plates. After 24 h, cells were treated with the H. pylori, as well as CagA protein, incubated at 37 ºC for 24, 48 or 72 h.
CCK8 (Dojindo CK40, Japan) was used to detect cell proliferation. Moreover, cells were treated with different inhibitors, including pEGFR (AG-1478), ERK (PD-98059), p-38 (SB-203580), SP1 (Mithramycin A), miRNA-1290 and FUT4 SiRNA. In brief, 10 µl CCK8 was added to the culture medium and incubation was continued for 4 h at 37 ºC. Absorbance was measured at 450 nm. The cell viability assay was also performed to determine the viability of gastric cancer cells by trypan blue exclusion assay. The test was performed in six replicates.
Semi-quantitative RT-PCR and real-time PCR
Total RNA was extracted by using the TRIzol® reagent (Invitrogen) and synthesized (Takara). The real-time PCR (qRT-PCR) was carried out according to the manufacturer's protocol (Takara) (Supplementary table1).
Immunoprecipitation assay
Immunoprecipitation assay was used to analyses the interaction between SP1 and ubiquitin. The SGC-7901 cells were treated with H. pylori CagA and harvested (3 x CagA protein treated as control. The assay was performed in triplicates.
Indirect immunofluorescent & immunocytochemical staining
Cells were grown on glass coverslips. After 48 h of CagA treatment, evaluated for rabbit anti-PCNA (1:100) and mouse anti-p-EGFR (1:100) as described [3] , [34] . Millipore, USA., anti-Ubiquitin (1:500) (Millipore) anti-EGFR (1:1000) and
Immunoblotting
anti-pEGFR (1:500), anti-ERK1/2 (1:500) and anti-pERK1/2 (1:500), anti-p38
(1:1000) and anti-pp38 (1:1000); (Transduction Laboratories, US), as described [3] , [34] .
Flow cytometry assay
Cells were gently trypsinized to prepare a single-cell suspension and were incubated with anti-PCNA (1:100), anti-p-EGFR (1:100), anti-FUT4 (1:100), and anti-LeY
(1:100) as described [3] , [34] .
Statistical analysis
Each experiment was repeated 3 times independently and results presented as the mean ± SEM. Statistical differences between test groups were analysed by paired Student's t-test and one-way analysis of variance (ANOVA) followed by (post hoc)
Newman-Keuls multiple comparison tests. Linearity of correlation was calculated by
the Pearson's coefficient correlation method. P<0.05 and P<0.01 were considered as significant. The statistical software GraphPad prism 5.03 was used for analyzing the data.
Results
H. pylori CagA induces gastric cancer cell proliferation with the regulation of EGFR/SP1 through miRNA-1290 overexpression
The role of H. pylori CagA was examined to determine the role of miRNA-1290 in the proliferation of gastric cancer cells. As shown in Figure 1 showed significantly high expression as compared to CagA treated cells (P<0.001) ( Figure 3H & Supplementary Fig. S3 ). However, the effect of H. pylori CagA on expression level of type I and type II Lewis antigens was analysed by Western blot and found significant effect of H. pylori CagA on LeB, LeX and sLeX as compared to
LeA expression level (P<0.01) (supplementary Fig. S4 ). Furthermore, FUT4 SiRNA transfection was showed negligible difference of miRNA-1290 level in CagA treated cells (P>0.001) ( Figure 4I ). These results are probable indications that H. pylori
CagA possibly stimulates the cell proliferation with up and down-regulation FUT4 fucosylation and SP1, respectively. However, FUT4 have no upstream role in the activation of miRNA-1290.
miRNA-1290 induces H. pylori treated gastric cancer cell proliferation through EGFR/SP1/FUT4/LeY pathway
In order to understand the mechanisms resulting in the promotion of gastric cancer cell proliferation through miRNA-1290 activation, SGC7901 cells were transfected with miRNA-1290 mimics; showed significant high cell proliferation and miRNA-1290 expression as compared to inhibitor and negative control ( Figure 4A 
miRNA-1290 inhibits SP1 expression through ubiquitination proteasomal pathway
In order to analyze the mechanism responsible for the degradation of SP1 protein, we examined the expression level of SP1 in miRNA-1290 treated cells, and we found negligible differences of SP1 mRNA level as compared to control (Figure. 5A); which proposed that SP1 is degraded in protein phase rather at mRNA level. We examined the potential role of ubiquitin-proteasomal pathway and found significantly high expression of ubiquitin protein level in response to miRNA-1290 treatment (P<0.001) ( Figure 5B) . Later, the direct interaction between sp1 and ubiquitin was determined by immunoprecipitation. As shown in Figure 5 , the role of ubiquitin activation showed that SP1 directly interact with ubiquitin-proteasomal system as we found significantly high expression of ubiquitin in miRNA mimics treated cells, as compared to miRNA-1290 inhibitor treated cells ( Figure. 5C, 5D ). These results predict the likely involvement of ubiquitin protein in the proteasomal degradation of SP1 protein with the activation of miRNA-1290 in H. pylori CagA treated gastric cancer cells.
Discussion
In recent years, the role of miRNAs in pathogenesis of gastric cancers has been extensively studied. However, little is known regarding on the association between miRNAs and cancer glycosylation responses in H.pylori-associated gastric cancer.
Recently, our lab was found a critical role of mir200b in the inhibition of breast cancer proliferation and metastasis by targeting fucosyltransferase IV and α 1,3-fucosylated glycans [37] . Previously, we reported that Rg3 drug stimulated gastric cancer cell apoptosis through FUT4 fucosylation by regulating SP1 and HSF1 expressions, which suggested oncogenic role of CagA in development of H. pylori associated gastric cancer [34] , [35] . Here, we investigated the detail mechanism of miRNA-1290 to promote gastric cancer cell proliferation by targeting SP1 through fucosyltransferase IV and α 1,3-fucosylated glycans. H. pylori CagA directly or indirectly induces various molecular changes in gastric epithelial cells, which facilitate the cell proliferation [38] . Previously, we reported that inhibition of EGFR phosphorylation downregulated gastric cancer cell proliferation through MAPKs pathways [39] . Hence, we evaluated the role of CagA on downstream molecules of EGFR and miR-1290 through MAPKs pathway. Our results showed that phosphorylation of EGFR were associated with up and down-regulation of miRNA-1290 and SP1 through ERK1/2 and p38 activation. According to Keates et al., H. pylori CagA positive strain was more potent to induce stronger MAPKs phosphorylation of ERK and p38 in AGS cell line [40] . These results proposed that miRNA-1290 is activated through EGFR/MAPKs phosphorylation by H. pylori CagA.
Hence, H. pylori CagA is a microbial factor associated with developmental risk of gastric cancer and its expression may have potential application as a marker for the evaluation of this risk.
H. pylori infection leads to the abnormal glycosylation and induced expression of the specific FUTs in gastric mucosa [41] , [42] , [43] . H. pylori can recognize a series of host glycosylated molecules, including LeY antigen which is predominately expressed by the mucous, chief and parietal cells of gastric glands [11] . Faisal et al.,
reported high expression of FUT4 and LeY in gastric cancer (97 & 92%) as compared to gastritis (82% & 85%) and gastric ulcer (82% & 85%) [35] . In this study, we found that H. pylori CagA is associated with high expression of FUT4 and LeY in gastric cancer cells with dose dependent manner. Furthermore, FUT4 inhibition proved that with the gastric epithelium surface by the host LeB, LeX and sLeX antigens [11] , [45] .
According to Wirth et al., high expression level of host Lewis antigen might be particularly adaptive in CagA strain of H.pylori [46] . Hence, there is a need to further investigate and analysed the role of H. pylori CagA on host LeA, LeB, LeX and sLeX antigen in correlation with their respected FUTs enzyme.
The detail mechanism of miRNA-1290 in the promotion of gastric cancer through FUT4/LeY fucosylation was further confirmed by using inhibition assay experiment.
We hypothesized that H. pylori CagA owned an ability to up-regulate miRNA-1290, suggested that ubiquitin protein is directly associated with the SP1 inhibition with the regulation of miR-1290. Hence, tumor suppressor transcription factor activity of SP1 is thought to negatively regulate the miRNA-1290 and followed to inhibit gastric cancer cell proliferation.
Conclusion:
Taken together, it is tempting to reveal that H. pylori CagA stimulates miRNA-1290 expression which target the SP1 protein expression in association with ubiquitin proteasomal system and facilitates the overexpression of FUT4 fucosylation and α 1,3-fucosylated glycans in the gastric epithelium ( Figure 6 ). This study provide a new interconnection between miRNA-1290 and gastric cancer fucosylation. Hence, miRNA-1290 can serve as promising target for interventional strategies towards gastric cancer treatment. 
Figure legends
